Robust Growth in Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Market

The benign prostatic hyperplasia (BPH) treatment devices and equipment market has exhibited robust growth, surging from $1.58 billion in 2023 to an estimated $1.69 billion in 2024, representing a notable compound annual growth rate (CAGR) of 7.0%. This positive trajectory is expected to continue, with the market reaching $2.14 billion by 2028, maintaining a steady CAGR of 6.1%.

Rising Prevalence of Benign Prostatic Hyperplasia (BPH):
The benign prostatic hyperplasia (BPH) treatment devices and equipment market is witnessing strong growth due to the increasing prevalence of Benign Prostatic Hyperplasia (BPH). This condition, also known as Prostate Gland Enlargement (PGE), is characterized by uncomfortable urinary symptoms. With over 14 million men in the United States and 30 million globally experiencing symptoms of BPH in 2021, the demand for BPH treatment devices and equipment is expected to rise steadily. As the number of BPH cases increases, so does the demand for devices tailored for effective treatment.

Increase in Prostate Cancer Cases:
The uptick in prostate cancer cases is anticipated to be a driving factor for the benign prostatic hyperplasia market. Prostate cancer, a type of cancer developing in the prostate gland, leads to a higher number of older men seeking medical attention for prostate-related issues, resulting in the identification and management of benign prostatic hyperplasia. With an estimated 288,300 men in the United States having prostate cancer in 2023, the correlation between prostate cancer and BPH is contributing to benign prostatic hyperplasia (BPH) treatment devices and equipment market growth.

Explore the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market with a Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=2431&type=smp

Prominent Market Players:
Major companies contributing to the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., Endo International PLC, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic PLC, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc.

Innovations in BPH Market with Prostatic Artery Embolization (PAE):
One of the latest developments in the benign prostatic hyperplasia (BPH) treatment devices and equipment market is Prostatic Artery Embolization (PAE). This minimally invasive treatment reduces urinary tract symptoms through X-ray-guided procedures without surgery. The market for PAE is witnessing investments from leading companies such as Boston Scientific, UNC Healthcare, and Spire Healthcare.

Innovations in BPH Treatment:
Major companies in the benign prostatic hyperplasia market are focusing on developing innovative products, such as the UroLift 2 System and the UroLift ATC advanced tissue control system. These technologies, launched by Teleflex Incorporated, aim to treat lower urinary tract symptoms due to BPH. The UroLift 2 System delivers permanent UroLift implants through the lobes of the prostate, while the UroLift ATC advanced tissue control system offers a minimally invasive procedure for treating enlarged prostate tissue.

Regional Landscape:
In 2023, North America emerged as the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market, with Western Europe following as the second-largest region globally. The comprehensive market report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Segmentation of BPH Treatment Devices and Equipment Market:
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented -
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

Access the Complete Report for In-Depth Analysis:
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on benign prostatic hyperplasia (BPH) treatment devices and equipment market size, benign prostatic hyperplasia (BPH) treatment devices and equipment market drivers and trends, benign prostatic hyperplasia (BPH) treatment devices and equipment market major players, benign prostatic hyperplasia (BPH) treatment devices and equipment market competitors' revenues, benign prostatic hyperplasia (BPH) treatment devices and equipment market positioning, and benign prostatic hyperplasia (BPH) treatment devices and equipment market growth across geographies. The benign prostatic hyperplasia (BPH) treatment devices and equipment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Nephrology Drugs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report
Urology Medical Lasers Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/urology-medical-lasers-global-market-report
Urology Devices Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/urology-devices-global-market-report

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model - Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

This release was published on openPR.